The propensity for developing atherosclerosis is dependent on underlying genetic risk, and varies as a function of age and exposure to environmental risk factors. Employing three mouse models with different disease susceptibility, two diets, and a longitudinal experimental design, it was possible to manipulate each of these factors to focus analysis on genes most likely to have a specific disease-related function. To identify differences in longitudinal gene expression patterns of atherosclerosis, we have developed and employed a statistical algorithm that relies on generalized regression and permutation analysis. Comprehensive annotation of the array with ontology and pathway terms has allowed rigorous identification of molecular and biological processes that underlie disease pathophysiology. The repertoire of atherosclerosis-related immunomodulatory genes has been extended, and additional fundamental pathways have been identified. This highly disease-specific group of mouse genes was combined with an extensive human coronary artery dataset to identify a shared group of genes differentially regulated among atherosclerotic tissues from different species and different vascular beds. A small core subset of these differentially regulated genes was sufficient to accurately classify various stages of the disease in mouse. The same gene subset was also found to accurately classify human coronary lesion severity. In addition, this classifier gene set was able to distinguish with high accuracy atherectomy specimens from native coronary artery disease versus those collected from in-stent restenosis lesions, thus identifying molecular differences between these two processes. These studies significantly focus efforts aimed at identifying central gene regulatory pathways that mediate atherosclerotic disease, and the identification of classification gene sets offers unique insights into potential diagnostic and therapeutic strategies in atherosclerotic disease.
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Introduction
Atherosclerosis is the primary cause of heart disease and stroke and thus the most common cause of morbidity and mortality worldwide (2, 3). The prolonged, chronic, and unpredictable nature of the disease in humans, which is a function of both genetic and environmental factors, has prohibited systematic temporal gene expression studies in humans. However, mouse genetic models of atherosclerosis do allow systematic analysis of gene expression, and provide a good representation of the human disease process (9).
ApoE-deficient mice predictably develop spontaneous atherosclerotic plaques with numerous features similar to human lesions (39, 40, 52). On a high-fat diet, the rate and extent of progression of lesions are accelerated. In addition to environmental influences such as diet, the genetic background of mice has also been found to have an important role in disease development and progression. Whereas, C57Bl/6 (C57) mice are susceptible to developing atherosclerosis, the C3H/HeJ (C3H) strain of mice are resistant (25, 56, 63) . It is imperative therefore to consider the genetic differences as well as environmental influences when studying atherosclerotic plaque-specific gene expression.
It is likely that the various stages of atherosclerosis are governed by a set of genes that are expressed by a variety of cell types present in the vessel wall (55). A small number of genes that are differentially expressed in vascular disease have been identified, and a few of these genes linked through mechanistic studies to disease processes (9, 22, 36). Recent efforts to identify disease related gene expression patterns have employed transcriptional profiling with DNA microarrays, however these studies have included relatively small arrays (67) as well as limited time-points, with the primary comparison being between normal and late stage diseased tissue (4, 18, 37, 50, 55, 70). Utilizing microarrays in animal models, where a disease process can be studied over time, the impact of individual risk factors and perturbations on the expression of individual genes during disease development can be studied systematically without a priori knowledge of
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gene identity. The temporal expression patterns of the genes can then be correlated with the well described disease stages. A recent transcriptional profiling study of apoE deficient mice suggested that temporal analysis would allow greater sensitivity for the identification of disease-related genes (67) . Transcriptional profiling of the entire aorta provides the benefit of studying complex interactions between multiple cell types and matrix during the time course of the disease development. Pathway enrichment methodologies used for analysis of the genes identified by this approach provide strong biological and analytical evidence for involvement of particular biological processes and molecular functions in the development and progression of atherosclerosis. Obviously, these whole tissue studies will have to be followed up with studies at the individual gene level to better understand the mechanisms and implications of their differential regulation.
To more fully characterize the vascular wall gene expression patterns that are associated with atherosclerosis, we have undertaken a systematic large scale transcriptional profiling study that takes advantage of a longitudinal experimental design, and mouse genetic model and diet combinations that provide varying susceptibility to atherosclerosis. Previously we have demonstrated the genetic-based diet and age induced transcriptional differences between these two strains (63). Here we turn our focus to study atherosclerosis-associated genes independent of other variables. Primarily, these studies have investigated differential gene expression over time in apoE-deficient mice on an atherogenic diet, with comparison to apoE-deficient mice (C57BL/6J-Apoe tm1Unc ) on normal diet as well as C57Bl/6 and C3H/HeJ mice on both normal chow and atherogenic diet.
Identification of atherosclerosis-associated genes was facilitated by development of permutation-based statistical tools for microarray analysis which takes advantage of the statistical power of time-course experimental design and multiple biological and technical
replicates. Using these tools, we have identified hundreds of known and novel genes that are involved in all stages of atherosclerotic plaque, from fatty streak to end stage lesions.
To further examine the expression of individual genes in the context of particular biological or molecular pathways we utilized pathway enrichment analysis with gene ontology (GO) terms for functional annotation. Using classification algorithms we were able to identify a signature pattern of expression for a core group of mouse atherosclerosis genes, and to validate the significance of these classifier genes with additional mouse and human atherosclerosis samples. These studies have identified atherosclerosis related genes and molecular pathways.
Methods
Atherosclerotic lesion analysis
For select time points of various experimental groups, 5 to 7 female mice were used for histological lesion analysis. Atherosclerosis lesion area was determined as described previously (63). Briefly, the arterial tree was perfused with PBS (pH 7.3) and then perfusion-fixed with phosphate-buffered paraformaldehyde (3%, pH 7.3). The heart and full length of the aorta to iliac bifurcation was exposed and dissected carefully from any surrounding tissues. Aortas were then opened along the ventral midline and dissected free of the animal and pinned out flat, intimal side up, onto black wax. Aortic images were captured with a Polaroid digital camera (DMC1) mounted on a Leica MZ6 stereo microscope, and analyzed using Fovea Pro (Reindeer Graphics, Inc. P. O. Box 2281, Asheville, NC 28802). Percent lesion area was calculated as total lesion area/total surface area.
Experimental design, RNA preparation and hybridization to microarrays
All experiments were performed following Stanford University animal care guidelines (53)
Three week old female apoE knock-out mice (C57BL/6J-Apoe for histology for quantification of atherosclerotic lesions as described above. A separate cohort of sixteen weeks old apoE deficient mice on high fat diet for two weeks (4 pools of 3 aortas) was also used for classification purposes. After perfusion of mice with saline, the aortas were carefully dissected in their entirety from the aortic root to the common iliacs and subsequently were flash frozen in liquid nitrogen. Total RNA was isolated as described previously (62) using a modified two-step purification protocol. RNA integrity was also assessed using the Agilent 2100 Bioanalyzer System with RNA 6000 Pico LabChip Kit (Agilent). First strand cDNA was synthesized from 10 µg of total RNA from each pool and from whole e17.5-day embryo for reference RNA in the presence of Cy5 or We then computed the signed area under the curve. The area is a natural measure of change over time. These areas were then used to compute an F-statistic for the 6 groups (3 mouse strains and 2 diets) and 3 replicates (between sum of squares/within sum of squares vs. a combination of the rest of the groups, "one vs. all" classifiers (49). The larger set of genes identified by the time-course analysis was used for this analysis. We then used this method to determine the optimal number of ranked genes to classify the experiments into their correct groups at minimal error rate. The optimal error rate or misclassification is calculated by cross-validation with 25% of the experiments as the test group and the rest as the training group. This is reiterated 1000 times (Fig 4A) . In this study we used a linear Kernel, since a nonlinear Gaussian kernel yielded similar results. Detailed methods are described online (publisher's website and reference (1)). This minimal subset of classifier genes was then used for cross-validation as well as classification of other independent gene expression profiling datasets.
vi) Analysis of independent datasets. We utilized the SVM algorithm for classification of independent groups of experiments (69) . In this analysis we used the primary time-course experiments (corresponding to 5 time points mentioned above) as the training set and the independent set of experiments (different array and labeling methodology) as the test set.
SVM output for each experiment based on one-versus-all comparisons were represented graphically in a heatmap format (Fig 4B) (Table 2 ). Detailed methods are described online (publisher's website and reference (1)).
Transcriptional profiling of human atherosclerotic tissue and atherectomy samples
Approval to use human tissue samples was granted by the Institutional Review Board of Stanford University. Informed consent was obtained from all participants. For one set of samples, coronary arteries were dissected from explanted hearts of patients undergoing orthotopic heart transplantation. Arteries were divided into 1.5 cm segments, classified as lesion or non-lesion after inspection of the luminal surface under a dissecting microscope.
RNA was isolated from each individual sample and hybridized to individual microarray. A central portion (1-2mm) of each segment was removed and stored in OCT for later histological staining (hematoxylin and eosin, Masson's trichrome). Samples (n=40) were derived from 17 patients (male 13, female 4, mean age 43 years). Six patients had a diagnosis of ischemic cardiomyopathy, while 11 were classified as non-ischemic, although some vessel segments from the latter had microscopic evidence of coronary artery disease. Of 21 diseased segments, 7 were classified as grade I, 4 grade III and 9 grade V, according to the modified American Heart Association criteria (66), and one sample had only macroscopic information available. For the second set of tissues, coronary atherectomy samples were obtained with a cutting atherectomy catheter system (Fox Hollow Inc., Redwood City, CA), for chronic atherosclerosis lesions (n=28) and in-stent restonsis lesions (n=14). Patient characteristics in both groups were similar (male 78% vs.
71%, mean age 64 vs. 67). RNA was isolated from each individual sample, labeled by direct or linear amplification methods, and hybridized as described above to a 22k feature 
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Results and Discussion
Atherosclerosis in the genetic models
To correlate the gene expression results with the extent of disease in each experimental group, the total atherosclerotic plaque burden in the aorta was determined by calculating a percent lesion area from the ratio of atherosclerotic area to total surface area. ApoEdeficient mice (C57BL/6J-Apoe tm1Unc ) (n=7) on high-fat diet were compared to other control mice (n=5-7 for each mouse-diet combination). Representative time-intervals were used for analysis including baseline measurements in mice prior to initiation of high-fat diet at 4
weeks as well as end-point measurements corresponding to 40 weeks on either high-fat or normal diet ( Fig. 1 ). Gross histological evaluation of these mice demonstrated increased atherosclerotic lesions in ApoE-deficient mice on high-fat diet involving about 50% of the entire aorta, and lesser area involved in ApoE-deficient mice on normal diet (Figs. 1B, C).
As expected, the control mice on either diet did not demonstrate evidence of atherosclerosis throughout the course of the experiment (30, 41). Although some fatty infiltrates were noted on histological evaluation of the aortic root in C57 mice on high-fat diet, there were no obvious changes in inflammatory cell infiltrate (63). The metabolic and lipid profiles of these mice were not obtained in this study given that they are well described in the literature (25, 41, 42). These studies have shown that C3H mice have consistently elevated cholesterol compared with C57 mice.
Temporal patterns of gene expression
Employing a number of mouse models with different propensity to develop atherosclerosis, two different diets, and a longitudinal experimental design, it was possible to factor out differentially regulated genes that are unlikely to be related to the vascular disease process in the apoE deficient model. For instance, age-related and diet-related gene expression patterns that are not linked to vascular disease were eliminated by virtue of
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their expression in the genetic models that did not develop atherosclerosis. However, the complexity of the experimental design provided significant difficulties related to statistical analysis. Although analytic methods have been proposed to address a single set of timecourse microarray data (35, 45, 46, 68), there was no accepted algorithm for comparing differences in patterns of gene expression across multiple longitudinal datasets.
Using principle component analysis (Supplemental Fig. A) we determined that the greatest variation in the data was between time points, correlating with the progression of disease described previously for the apoE knockout mouse on high fat diet (39, 52 667 genes demonstrated a linear increase with time, whereas only 64 genes showed the opposite profile (Fig. 2) . Genes and biological pathways whose expression is correlated with degree of atherosclerosis are prime candidates for further scientific investigation as well as important targets for future diagnostic and therapeutic strategies.
Genes with increased expression in the atherosclerotic vessel wall
As expected, we identified a number of known genes previously linked to atherosclerosis, including Timp1, were also among the upregulated genes. Many transcription factors, lipid metabolism and vascular calcification genes, as well as macrophage and smooth muscle cell specific genes were among those found to be upregulated. New genes were identified in each of these classes, for example, members of the ATP-binding-cassette family not previously associated with atherosclerosis were identified through these studies, including
Abcc3 and Abcb1b.
Interesting genes linked to atherosclerosis for the first time through these studies 
Genes with decreased expression in the atherosclerotic vessel wall
The 64 genes that showed decreased expression during progression of atherosclerosis were of interest, given the lack of previous attention to such genes. Genes that are Other downregulated skeletal and cardiac muscle genes included calsequesterin, which is expressed in fast-twitch skeletal muscle, Usmg4, which is upregulated during skeletal muscle growth, Xin, which is involved in cardiac and skeletal muscle development, and
Sgcg, that is strongly expressed in skeletal and heart muscle as well as proliferating myoblasts. The possible association of these and other myocyte/smooth muscle related genes identified in our study to normal vascular function is not known, but deserves further study.
Pathways analysis
To identify important biological themes represented by genes differentially expressed in the atherosclerotic lesions, we functionally annotated the genes using Gene Ontology (GO) terms (20) In addition to inflammation, other biological processes and molecular functions were over-represented in the group of differentially upregulated genes. These included expected pathways such as wound healing, ossification, proteo-and peptidolysis, apoptosis, nitric oxide mediated signal transduction, cell adhesion and migration, and scavenger receptor activity. However, several pathways that are less known for their role in atherosclerosis were also identified, including carbohydrate metabolism, complement activation, calcium ion homeostasis, collagen catabolism, glycosyl bonds and hydrolase activity, taurine transporter activity, heparin activity, etc. The lack of oxygen radical metabolism among the significant processes was surprising, but consistent with upregulation of genes related to oxygen radical metabolism in all groups with aging.
Taken together, these pathway analyses support prior observations regarding the importance of inflammatory molecular pathways in atherosclerosis, but additionally, expand the repertoire of molecular pathways that are involved in this disease process.
Such analyses can also be used to shed light on molecular mechanisms of action of current and future atherosclerosis therapies.
Identification of genes involved in early atherogenesis and other time-related expression patterns in atherosclerosis
The above analysis has examined in detail those genes with increasing expression level, which correlates with atherosclerotic plaque development. However, additional patterns of
PG-00001-2005.R2
gene expression may also be identified in these longitudinal studies, and may identify classes of genes and pathways not previously identified. Almost all previous studies have looked at late stages of atherosclerosis. Because of or longitudinal design, we have also been able to identify genes which are transiently regulated at early stages of the disease which could act as early diagnostic markers of disease. For these analyses we have employed the AUC algorithm, which measured expression changes over time, made comparisons between the different strain/diet longitudinal datasets to identify gene expression changes specific for the apoE knockout model on high-fat diet, and employed permutation to estimate the FDR (63). Using this methodology we are able to identify several distinct gene expression patterns and pathways that reflect particular biological processes ( Employing the SVM classification algorithm we were able to identify 38 genes that were able to accurately classify each experiment with one of five defined stages of atherosclerosis in mice (Fig. 4A) . Our results demonstrated that these genes can distinguish normal from severe lesions with 100% accuracy. The intermediate stages of the disease are also distinguished from the other stages with a high degree of accuracy (88-97%) ( Table 2 ).
The validity of a set of classifier genes can be demonstrated by its ability to correctly classify independent tissues analyzed using different arrays and techniques. We therefore investigated the ability of the gene identified by SVM to accurately categorize an independent group of 16 week old apoE knockout mice, which were evaluated with a different array and labeling methodology. In the later case the microarray has utilized different probes for some of the same genes. Moreover, the labeling methodology for these arrays uses a linear amplification step. Using the SVM classification algorithm we were able to accurately classify each of the 4 replicate experiments with the correct stage of the disease process (Fig. 4B) . As indicated by the greater correlation between gene expression in this independent group of mice and gene expression patterns in the original experimental group aged 24 weeks, the classifier genes accurately matched this validation dataset to the closest time-point in the database. This approach offers a potentially novel
platform for drug development where unique signature patterns of gene expression can be used to assay the efficacy of potential therapeutic compounds in altering the progression of atherosclerosis.
Identification of mouse disease gene expression patterns in human coronary atherosclerosis
The goal of these mouse model studies was to gain information that could be applied to understanding of human coronary artery disease. However, the differences in species, the disparate vascular beds involved, and the specific lipid-driven nature of disease in the apoE knockout, make direct extrapolation of individual gene expression data to human disease problematic. Thus, we investigated the expression profile of differentially regulated mouse genes in human coronary artery atherosclerosis. For transcriptional profiling of human atherosclerotic plaque, we used 40 coronary artery samples dissected from explanted hearts of 17 patients undergoing orthotopic heart transplantation. Of the 21 diseased segments, lesions ranged in severity from grade I to V (modified American Heart Association criteria based on morphological description (66)). For the purpose of this analysis, human artery segments were classified as non-lesion or lesion (combined all grades). Atherosclerosis related mouse genes were matched to human orthologs by gene symbol or by known homology (26). Comparison of expression of the mouse genes between lesion and non-lesion human samples using the significance analysis of microarrays algorithm (FDR <0.025) revealed more than 100 mouse genes with higher expression in the diseased human tissue (Fig. 5 , supplemental Table C) . Given the differences between the tissue samples used in these gene expression experiments, these are highly likely to constitute an important common set of disease relevant genes.
To further test the relevance of our findings in mouse atherosclerosis, we studied the accuracy of the mouse classifier genes in human atherosclerotic disease, employing (Table 2) .
Additionally, we used the mouse classifiers genes to categorize human atherectomy tissue obtained from coronary vessels treated for chronic atherosclerosis or in-stent restenosis. The pathophysiological basis of restenosis is quite distinct from that of chronic coronary atherosclerosis, and it was of interest to demonstrate that our classifiers genes could distinguish the disease processes (47). Our results (Table 2) aortas from fifteen mice were combined into three pools for microarray replicate studies.
To eliminate gene expression differences due to aging, diet and genetic differences, a number of control groups were also used at each time point, including apoE deficient mice on normal chow as well as C57Bl/6 and C3H/HeJ wildtype mice on both normal Identification of the classification gene set. The SVM algorithm was employed to rank genes based on their ability to accurately discriminate between five time points in apoE deficient mice on high fat diet. An optimal set of 38 genes was identified to classify the experiments at a minimal error rate of 15%. The optimal 15% error rate was determined with a 1000 step cross-validation method with 25% of the experiments employed as the test group and the rest as the training group. Some of the genes identified were well known genes such as Ccr2, Spp1, and C1q, while others were non-obvious classifiers.
( Table 2 . Classification of mouse and human atherosclerotic tissues employing mouse classifier genes. To validate the accuracy of mouse classifier genes in predicting disease severity we utilized various mouse and human expression datasets. The SVM algorithm was utilized for cross validation of mouse experiments grouped on the basis of (A) stage of disease (no disease-apoE time 0, mild disease-apoE at 4 and 10 weeks on normal diet, mild-moderate diseaseapoE at 4 and 10 weeks on highfat diet, moderate disease-apoE at 24 and 40 weeks on normal diet, and severe disease-apoE at 24 and 40 weeks on high fat diet); (B) 3 different time points (apoE at 0 vs. 10, vs. 40 weeks); (C) Human coronary artery with lesion vs. no lesion; and (D) atherectomy samples derived from in-stent restenosis vs. native atherosclerotic lesions. For each analysis, the accuracy of classification is represented in tabular fashion with the confusion matrix generated using N-fold cross validation methods. Number of classifier genes % misclassifications Validation of mouse genes in human atherosclerotic plaques Symbol Gene Name Score(d) Fold Change RGS10 regulator of G-protein signalling 10
